| Literature DB >> 29184086 |
Zhe Xu1, Weibo Li1, Jun Jiang1, Xiran Zhuang1, Wei Chen1, Mei Peng1, Jianhua Wang2, Fan Lu1, Meixiao Shen3, Yuanyuan Wang4,5,6.
Abstract
The study aimed to characterize the entire corneal topography and tomography for the detection of sub-clinical keratoconus (KC) with a Zernike application method. Normal subjects (n = 147; 147 eyes), sub-clinical KC patients (n = 77; 77 eyes), and KC patients (n = 139; 139 eyes) were imaged with the Pentacam HR system. The entire corneal data of pachymetry and elevation of both the anterior and posterior surfaces were exported from the Pentacam HR software. Zernike polynomials fitting was used to quantify the 3D distribution of the corneal thickness and surface elevation. The root mean square (RMS) values for each order and the total high-order irregularity were calculated. Multimeric discriminant functions combined with individual indices were built using linear step discriminant analysis. Receiver operating characteristic curves determined the diagnostic accuracy (area under the curve, AUC). The 3rd-order RMS of the posterior surface (AUC: 0.928) obtained the highest discriminating capability in sub-clinical KC eyes. The multimeric function, which consisted of the Zernike fitting indices of corneal posterior elevation, showed the highest discriminant ability (AUC: 0.951). Indices generated from the elevation of posterior surface and thickness measurements over the entire cornea using the Zernike method based on the Pentacam HR system were able to identify very early KC.Entities:
Mesh:
Year: 2017 PMID: 29184086 PMCID: PMC5705674 DOI: 10.1038/s41598-017-16568-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Clinical information of all subjects for normal, sub-clinical KC, and KC groups.
| Group (eyes/subjects) | Normal (147/147) | Sub-clinical KC (77/77) | KC (139/139) |
|---|---|---|---|
|
| |||
| Spherical equivalent (D) | −3.93 ± 2.26 | −3.68 ± 3.25 | −6.85 ± 4.14†* |
| (95%CI) | (−4.29 to −3.56) | (−4.41 to −2.95) | (−7.54 to −6.16) |
| Astigmatism keratometry (D) | 1.26 ± 0.67 | 1.46 ± 0.70 | 5.14 ± 3.13†* |
| (95%CI) | (1.15 to 1.37) | (1.30 to 1.62) | (4.61 to 5.66) |
| Average keratometry (D) | 43.63 ± 1.41 | 43.51 ± 1.13 | 48.72 ± 4.42†* |
| (95%CI) | (43.40 to 43.86) | (43.26 to 43.77) | (47.98 to 49.46) |
| BCVA (decimal VA) | 1.06 ± 0.10 | 1.01 ± 0.10 | 0.56 ± 0.27†* |
| (95%CI) | (1.04 to 1.07) | (0.99 to 1.04) | (0.51 to 0.60) |
|
| |||
| K | 43.72 ± 1.60 | 43.78 ± 1.26 | 49.53 ± 4.86†* |
| (95%CI) | (43.46 to 43.98) | (43.49 to 44.06) | (48.72 to 50.34) |
| I-S | −0.11 ± 0.62 | 0.28 ± 0.71* | 3.32 ± 2.00†* |
| (95%CI) | (−0.21 to −0.01) | (0.12 to 0.44) | (2.99 to 3.66) |
| AST | 1.33 ± 0.72 | 1.49 ± 0.68 | 4.52 ± 2.23†* |
| (95%CI) | (1.22 to 1.45) | (1.34 to 1.65) | (4.15 to 4.90) |
| SRAX | 24.10 ± 28.84 | 46.70 ± 50.87* | 94.77 ± 49.12†* |
| (95%CI) | (19.43 to 28.78) | (35.26 to 58.14) | (86.58 to 102.97) |
| KISA% | 9.25 ± 12.40 | 22.87 ± 34.48* | 2192.87 ± 3857.85†* |
| (95%CI) | (7.24 to 11.26) | (15.12 to 30.62) | (1549.20 to 2836.54) |
|
| |||
| Anterior flatkeratometry (D) | 42.82 ± 1.29 | 42.57 ± 1.19 | 49.45 ± 18.53†* |
| (95%CI) | (42.61 to 43.03) | (42.30 to 42.84) | (46.36 to 52.55) |
| Anterior steep keratometry (D) | 43.91 ± 1.58 | 43.96 ± 1.27 | 52.18 ± 6.60†* |
| (95%CI) | (43.65 to 44.16) | (43.67 to 44.25) | (51.08 to 53.29) |
| Anterior average keratometry (D) | 43.35 ± 1.38 | 43.25 ± 1.15 | 50.00 ± 5.98†* |
| (95%CI) | (43.13 to 43.58) | (42.99 to 43.51) | (49.00 to 50.99) |
| Anterior maximum keratometry (D) | 44.71 ± 1.65 | 45.11 ± 1.45 | 58.60 ± 9.26†* |
| (95%CI) | (44.44 to 44.98) | (44.78 to 45.43) | (57.06 to 60.15) |
| Posterior flat keratometry (D) | 6.08 ± 0.40 | 6.12 ± 0.29 | 7.16 ± 1.04†* |
| (95%CI) | (6.02 to 6.15) | (6.06 to 6.18) | (6.98 to 7.33) |
| Posterior steep keratometry (D) | 6.45 ± 0.26 | 6.48 ± 0.29 | 8.02 ± 1.25†* |
| (95%CI) | (6.40 to 6.49) | (6.42 to 6.55) | (7.81 to 8.23) |
| Posterior average keratometry (D) | 6.27 ± 0.22 | 6.29 ± 0.27 | 7.56 ± 1.12†* |
| (95%CI) | (6.24 to 6.31) | (6.23 to 6.35) | (7.37 to 7.75) |
| TCT | 530.42 ± 25.44 | 508.11 ± 32.39* | 446.92 ± 49.81†* |
| (95%CI) | (526.29 to 534.55) | (500.83 to 515.40) | (438.61 to 455.23) |
| AEmax | 3.80 ± 1.59 | 6.37 ± 2.69* | 29.05 ± 15.80†* |
| (95%CI) | (3.54 to 4.06) | (5.76 to 6.98) | (26.41 to 31.69) |
| PEmax | 8.00 ± 2.82 | 16.12 ± 7.59* | 63.83 ± 33.49†* |
| (95%CI) | (7.55 to 8.46) | (14.41 to 17.83) | (58.24 to 69.41) |
Normal, normal group; Sub-clinical KC, sub-clinical keratoconus group; KC, keratoconus group; BCVA, best corrected visual acuity; 95% CI, 95% confidence interval.
*Compared to the normal group P < 0.05 by one way ANOVA LSD test.
†Compared to the sub-clinical KC group P < 0.05 by one way ANOVA LSD test.
The diagnostic indices with significant difference for sub-clinical KC and KC.
| Diagnostic indices | Normal | Sub-clinical KC | KC | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean | Mean | AUC | cut off | Sen (%) | Spe (%) | Mean | AUC | cut off | Sen (%) | Spe (%) | |
|
| |||||||||||
| 3rd order RMS | 1.587 ± 0.729 | 2.631 ± 1.440* | 0.751 | 1.852 | 68 | 78 | 11.473 ± 5.825†* | 0.974 | 4.992 | 88 | 93 |
| 5th order RMS | 0.428 ± 0.260 | 0.602 ± 0.237* | 0.749 | 0.455 | 71 | 70 | 2.262 ± 1.219†* | 0.978 | 1.084 | 88 | 100 |
| 6th order RMS | 0.284 ± 0.154 | 0.403 ± 0.171* | 0.734 | 0.351 | 61 | 86 | 1.255 ± 1.225†* | 0.917 | 0.577 | 84 | 86 |
| HOI RMS | 3.268 ± 0.584 | 3.816 ± 1.239* | 0.638 | 3.720 | 39 | 90 | 13.413 ± 7.088†* | 0.980 | 6.302 | 90 | 96 |
|
| |||||||||||
| 3rd order RMS | 2.439 ± 0.716 | 5.774 ± 2.301* | 0.926 | 3.829 | 79 | 96 | 14.697 ± 7.351†* | 0.891 | 8.596 | 82 | 94 |
| 5th order RMS | 1.302 ± 0.388 | 1.836 ± 1.023* | 0.698 | 1.436 | 68 | 72 | 3.913 ± 1.923†* | 0.805 | 2.805 | 74 | 93 |
| HOI RMS | 4.489 ± 0.776 | 7.142 ± 2.723* | 0.824 | 5.587 | 68 | 92 | 18.266 ± 8.842†* | 0.904 | 11.757 | 80 | 96 |
|
| |||||||||||
| 3rd order RMS | 3.299 ± 1.232 | 8.248 ± 3.631* | 0.928 | 4.597 | 86 | 88 | 27.362 ± 13.153†* | 0.947 | 13.474 | 90 | 93 |
| 5th order RMS | 1.569 ± 0.499 | 2.318 ± 1.291* | 0.704 | 1.704 | 64 | 68 | 6.404 ± 3.233†* | 0.952 | 3.896 | 80 | 96 |
| HOI RMS | 8.314 ± 1.214 | 11.037 ± 3.715* | 0.699 | 10.156 | 54 | 96 | 32.646 ± 16.324†* | 0.911 | 14.991 | 92 | 90 |
|
| |||||||||||
| I-S | −0.072 ± 0.689 | 0.287 ± 0.673* | 0.681 | 0.245 | 64 | 71 | 3.254 ± 1.988†* | 0.996 | 1.905 | 95 | 100 |
| SRAX | 24.265 ± 27.270 | 49.357 ± 54.621* | 0.612 | 8.500 | 85 | 35 | 89.500 ± 51.090†* | 0.737 | 32.500 | 85 | 64 |
| KISA% | 10.373 ± 14.210 | 19.492 ± 23.139* | 0.645 | 9.267 | 54 | 74 | 2144.832 ± 3883.942†* | 0.959 | 97.000 | 81 | 100 |
|
| |||||||||||
| TCT | 530.873 ± 25.567 | 509.036 ± 29.902* | 0.695 | 498.835 | 92 | 47 | 450.667 ± 41.148†* | 0.862 | 479.5 | 83 | 78 |
| AEmax | 3.896 ± 1.636 | 6.155 ± 2.507* | 0.812 | 4.585 | 72 | 73 | 27.466 ± 14.182†* | 0.974 | 11.165 | 92 | 93 |
| PEmax | 7.953 ± 2.989 | 16.167 ± 7.185* | 0.856 | 12.335 | 93 | 67 | 60.748 ± 29.935†* | 0.970 | 30.165 | 94 | 88 |
Normal, normal group; Sub-clinical KC, sub-clinical keratoconus group; KC, keratoconus group; AUC, area under receiver operating characteristic curve; Sen, sensitivity; Spe, specificity; RMS, the values of root mean square; HOI, higher-order irregularity.
*Compared to the normal group P < 0.05 by one way ANOVA LSD test.
†Compared to the sub-clinical KC group P < 0.05 by one way ANOVA LSD test.
Formulas of the discriminant functions.
| Discriminant Functions | Formulas |
|---|---|
| DT | 0.212* T3rd order − 1.675 |
| DA | 0.862* A3rd order + 1.04* A6th order − 0.64* AHOI − 0.887 |
| DP | −0.077* PHOI + 0.203* P3rd order − 1.37 |
| DTA | 0.675* A3rd order + 0.770* A6th order − 0.518* AHOI + 0.086* T3rd order − 1.229 |
| DTP | −0.077* PHOI + 0.203* P3rd order − 1.37 |
| DAP | 0.116* A3rd order + 0.989* A6th order − 0.251* PHOI + 0.307* P3rd order − 0.942 |
| DTAP | 0.148* THOI + 0.257* A3rd order + 0.816* A6th order − 0.307* PHOI + 0.238* P3rd order − 1.189 |
A, the anterior surface; P, the posterior surface; T, the corneal thickness; certain order, the root mean square of certain order; HOI, the root mean square of total higher-order irregularity.
The output values of discrimination functions constructed from Zernike RMS metrics with significant differences for sub-clinical KC and KC.
| Discrimination | Normal | Sub-clinical KC | KC | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| functions | mean | mean | AUC | cut off | Sen (%) | Spe (%) | mean | AUC | cut off | Sen (%) | Spe (%) |
| DT | −1.158 ± 0.152 | −0.451 ± 0.488* | 0.927 | −0.863 | 79 | 96 | 1.441 ± 1.558†* | 0.891 | 0.148 | 83 | 93 |
| DA | −1.316 ± 0.464 | −0.641 ± 0.626* | 0.798 | −0.931 | 71 | 82 | 1.723 ± 1.469†* | 0.967 | 0.180 | 87 | 96 |
| DP | −1.340 ± 0.209 | −0.546 ± 0.475* | 0.951 | −1.040 | 89 | 94 | 1.671 ± 1.549†* | 0.933 | 0.191 | 85 | 96 |
| DTA | −1.381 ± 0.414 | −0.540 ± 0.808* | 0.876 | −1.021 | 79 | 88 | 1.787 ± 1.509†* | 0.970 | 0.262 | 91 | 96 |
| DTP | −1.340 ± 0.209 | −0.546 ± 0.475* | 0.951 | −1.040 | 89 | 94 | 1.671 ± 1.549†* | 0.933 | 0.191 | 85 | 96 |
| DAP | −1.551 ± 0.419 | −0.476 ± 0.598* | 0.926 | −1.117 | 89 | 84 | 1.835 ± 1.478†* | 0.946 | 0.574 | 87 | 100 |
| DTAP | −1.653 ± 0.461 | −0.552 ± 0.627* | 0.918 | −1.179 | 89 | 86 | 1.976 ± 1.458†* | 0.974 | 0.530 | 87 | 100 |
Normal, normal group; Sub-clinical keratoconus, sub-clinical keratoconus group; KC, keratoconus group; AUC, area under receiver operating characteristic curve; Sen, sensitivity; Spe, specificity.
*Compared to the normal group P < 0.05 by one way ANOVA LSD test.
†Compared to the sub-clinical KC group P < 0.05 by one way ANOVA LSD test.
Figure 1Receiver operating characteristic (ROC) curves of discriminant functions for normal, sub-clinical KC, and KC groups. (A) ROC curve of the output value of discriminant functions for sub-clinical KC group versus normal group. (B) ROC curve of the output value of discriminant functions for KC group versus sub-clinical KC group.
Confusion matrix (actual vs predicted group), accuracy, precision, sensitivity, specificity of the diagnostic indices and discrimination functions performed on the validation set.
| Actual Group | Total | Predicted Group | Accuracy (%) | Precision (%) | Sensitivity (%) | Specificity (%) | ||
|---|---|---|---|---|---|---|---|---|
| Normal | Sub-clinical KC | |||||||
|
|
| 97 | 84 | 13 | 82.2 | 73.5 | 73.5 | 86.6 |
|
| 49 | 13 | 36 | |||||
|
|
| 97 | 82 | 15 | 79.5 | 69.4 | 69.4 | 84.5 |
|
| 49 | 15 | 34 | |||||
|
|
| 97 | 86 | 11 | 84.2 | 77.1 | 75.5 | 88.7 |
|
| 49 | 12 | 37 | |||||
|
|
| 97 | 86 | 11 | 84.9 | 77.6 | 77.6 | 88.7 |
|
| 49 | 11 | 38 | |||||
|
|
| 97 | 86 | 11 | 84.2 | 77.1 | 75.5 | 88.7 |
|
| 49 | 12 | 37 | |||||
|
|
| 97 | 78 | 19 | 80.8 | 67.8 | 81.6 | 80.4 |
|
| 49 | 9 | 40 | |||||
|
|
| 97 | 82 | 15 | 84.2 | 73.2 | 83.7 | 84.5 |
|
| 49 | 8 | 41 | |||||
|
|
| 97 | 76 | 21 | 71.9 | 58.0 | 59.2 | 78.4 |
|
| 49 | 20 | 29 | |||||
|
|
| 97 | 34 | 63 | 51.4 | 39.4 | 83.7 | 35.1 |
|
| 49 | 8 | 41 | |||||
|
|
| 97 | 75 | 22 | 69.9 | 55.1 | 55.1 | 77.3 |
|
| 49 | 22 | 27 | |||||
|
|
| 97 | 89 | 8 | 77.4 | 75.0 | 49.0 | 91.8 |
|
| 49 | 25 | 24 | |||||
|
|
| 97 | 71 | 26 | 72.6 | 57.4 | 71.4 | 73.2 |
|
| 49 | 14 | 35 | |||||
|
|
| 97 | 90 | 7 | 83.6 | 82.1 | 65.3 | 92.8 |
|
| 49 | 17 | 32 | |||||
Normal, normal group; Sub-clinical KC, sub-clinical keratoconus group; KC, keratoconus group.